Skip to content

Wearable Sensors and Video Recordings to Monitor Motor Development

Wearable Sensors and Video Recording for Children (Birth to 24 Months) to Monitor Motor Development

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03770832
Enrollment
150
Registered
2018-12-10
Start date
2019-03-29
Completion date
2026-12-01
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Disability, Motor Delay, Neurodevelopmental Disorders

Keywords

Early Detection, Wearable Sensors, Computer Vision

Brief summary

The objective of this study is to develop an automated, precise, quantitative assay for detecting atypical motor behavior and development in infants using data from wearable sensors and video recordings.

Interventions

None listed

Sponsors

Shirley Ryan AbilityLab
Lead SponsorOTHER
Ann & Robert H Lurie Children's Hospital of Chicago
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
University of Illinois at Chicago
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Individuals identified as potentially at risk of abnormal motor development due to a risk factor (for example, prematurity, neonatal hypoxic ischemic encephalopathy, or neonatal stroke) OR control individuals for whom normal motor development is expected. * Age: \< 24 months of age * Legal guardian able and willing to give written consent and comply with study procedures. * In case of multiple pregnancies, only one child selected at random will participate in the research activities. Study staff will have no influence over the selection, besides any known medical condition automatically excluding the baby as listed in our

Exclusion criteria

.

Design outcomes

Primary

MeasureTime frameDescription
Three month clinical score estimation3 monthsError between true clinical test scores and scores estimated from sensor and video data, assessed at the 3 month time-point.
Six month clinical score estimation6 monthsError between true clinical test scores and scores estimated from sensor and video data, assessed at 6 month time-point.
Prediction of neuromotor outcome using sensor and video data from 3 month time-point3 monthsSensitivity and specificity of algorithm (trained on sensor and video data from the 3 month time-point) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\])
Prediction of neuromotor outcome using sensor and video data from 6 month time-point6 monthsSensitivity and specificity of algorithm (trained on sensor and video data from the 6 month time-point) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\])

Secondary

MeasureTime frameDescription
Prediction of neuromotor outcome using General Movements Assessment (GMA) scores1-2 weeks, 1 month, 3 monthsSensitivity and specificity of GMA scores (taken at 1-2 weeks, 1 month, 3 months) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\]). The GMA is an observational exam where an infant's spontaneous movements are scored as atypical or normal for their age.
Prediction of neuromotor outcome using Alberta Infant Motor Scale (AIMS) scores6 months, 9 months, 1 yearSensitivity and specificity of AIMS scores (taken at 6 months, 9 months, 1 year) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\]). The AIMS is a norm-referenced observational assessment with a minimum score of 0 and a maximum score of 58. Higher scores indicate better motor performance on the assessment.
Prediction of neuromotor outcome using Hammersmith Infant Neurological Examination (HINE) scores6 months, 9 months, 1 yearSensitivity and specificity of HINE scores (taken at 6 months, 9 months, 1 year) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\]). The HINE is a neurological exam with a minimum score of 0 and a maximum score of 78. Higher scores indicate better performance on the assessment.
Prediction of neuromotor outcome using Test of Infant Motor Performance (TIMP) scores1-2 weeks, 1 month, 3 monthsSensitivity and specificity of TIMP scores (taken at 1-2 weeks, 1 month, 3 months) to predict neuromotor outcome at final study visit (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\]).
Clinical score estimation1-2 weeks, 1 month, 9 months, 1 year, 2 yearsError between true clinical test scores and scores estimated from sensor and video data, assessed at each remaining time-point.
Prediction of neuromotor outcome at 2 years using sensor and video data from the remaining time-points1-2 weeks, 1 month, 9 months, 1 year, 2 yearsSensitivity and specificity of algorithm (trained on sensor and video data from the remaining time-points) to predict neuromotor outcome at 2 years (as measured by the Peabody Developmental Motor Scales, second edition \[PDMS-2\])

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORArun Jayaraman, PT, PhD

Shirley Ryan AbilityLab

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026